NeurAxis, Inc. logo

NRXS Earnings Date: Nov 9, 2026 (Estimated) — NeurAxis, Inc.

AMEX · Healthcare · Biotechnology

Updated

Price $7.33
Market Cap $92.0M
P/E -9.6
52W Range $2.21 – $9.33
Next Earnings · After close (est.)

When is NRXS's next earnings date?

NeurAxis, Inc. (NRXS) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 5:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.21 on revenue of $2.1M.

How did NRXS do in its last earnings report?

In its most recent report on Aug 11, 2026 (Q2 2026), NeurAxis, Inc. posted EPS of -$0.19 versus the -$0.32 estimate, a beat of 40.6%. Revenue was $1.9M against a $2.0M estimate. The stock's 1-day post-earnings move was -7.6%.

How much does NRXS stock move after earnings?

NRXS beat EPS estimates in 3 of its last 5 reported quarters. Over the last 8 reports the stock moved an average of 4.3% (up or down) in the day after earnings.

About NeurAxis, Inc.

NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-11Q2 2026-0.32-0.19+40.62%$1.9M✅ Beat-7.57%-8.59%-16.59%
2026-05-12Q1 2026-0.19-0.18+5.26%$1.6M✅ Beat+1.47%-9.08%-16.56%
2026-03-19Q4 2025-0.21-0.17+19.05%$968,127✅ Beat+2.43%+7.44%+3.29%
2025-11-10Q3 2025-0.20-0.24-20.00%$811,414❌ Miss-5.86%-9.77%+7.81%
2025-08-12Q2 2025-0.19-0.22-15.79%$894,086❌ Miss+2.47%+2.06%+0.41%
2025-03-20Q4 2024—-0.23—$761,165—-0.87%-6.11%-30.13%
2024-08-09Q2 2024—-0.42—$611,500—+9.12%+10.00%+10.18%
2024-05-22Q1 2024—-0.32—$646,635—-4.59%+7.54%-15.41%

Showing last 8 quarters.

Revenue by segment & region

By region

Q4 FY23 · $699K total

SegmentShareRevenueYoY
All Other States67.7%$473K—
OHIO18.5%$129K—
FLORIDA13.8%$96K—

Source: company filings via FMP. YoY compares the same fiscal period a year earlier.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .